There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report), IVERIC bio (ISEE – Research Report) and Travere Therapeutics (TVTX – Research Report) with bullish sentiments. DENTSPLY SIRONA (XRAY) Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on DENTSPLY SIRONA yesterday and set a price target of $65.00. The company's shares closed last Tuesday at $48.63, close to its 52-week low of $47.40. According to TipRanks.com, CFA is ranked 0 out of 5 stars with an average return of -22.4% and a 33.3% success rate.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dentsply-sirona-xray-iveric-bio-isee-and-travere-therapeutics-tvtx?utm_source=advfn.com&utm_medium=referral
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Ago 2022 até Set 2022 Click aqui para mais gráficos DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Set 2021 até Set 2022 Click aqui para mais gráficos DENTSPLY SIRONA.